Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Comprehensive financial planning is vital for long-term success. Understand its importance in achieving your financial goals.
18,030 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Gold soars to $5,100 an ounce as major indices retreat and oil prices climb, signaling a shift toward hedges and new ...
When a large hedge fund reduces its Celcuity stake, markets pay attention. This article breaks down the move, what it...
As XRP trades near $1.43, analysts weigh whether a $10 price is possible and outline the five catalysts and macro con...
Oil prices rose above $100 a barrel after a large emergency stockpile release. Yet investor fears lingered about supp...
January data shows the fed's favored inflation gauge staying elevated, underscoring persistent price pressures as pol...
Could XRP slip below $2 by 2027? This guide breaks down the three big hurdles, explains why a lower price is plausibl...
Energy Transfer sits at the heart of U.S. energy infrastructure. This guide explains when energy transfer stock right...
Dreaming of a portfolio that compounds for decades? This article lays out three growth stocks hold forever that pass ...
NVIDIA just reported billion-dollar revenue, underscoring a surge in AI infrastructure spending. This article explain...
Lawmakers push a roadmap for crypto regulation with an April vote and a May passage deadline. This article breaks dow...
A new deduction for interest on auto loans for 2025 buyers could cut tax bills even for standard-deduction filers. Bu...